Europe Dry Eye Syndrome Market Size and Share | Forecast - 2022-27
According to the latest report by IMARC Group, titled, “Europe Dry Eye Syndrome Market Size: Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027″, The Europe dry eye syndrome market is projected to reach a strong growth during the forecast period (2022-2027).-
Dry eye syndrome, or keratoconjunctivitis sicca (KCS), is a multifactorial disorder of the tear duct and ocular surface that results in the lack of lubrication on the surface of the eye. It is characterized by a stinging sensation, stringy mucus around the eyes, blurred vision, and photophobia. Dry eye syndrome is often caused due to decreased tear production or increased tear evaporation. It can be effectively treated through surgeries, medications, and administering artificial tears.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts, are being done after considering the impact of this pandemic.
Europe Dry Eye Syndrome Market Trends:
The Europe dry eye syndrome market is primarily driven by the growing geriatric population. This, in confluence with the increasing prevalence of ocular diseases among the masses, has escalated market growth. Furthermore, growing investments by multiple pharmaceutical companies in the development of new therapeutics and the increasing awareness among people regarding the success rates of accessible treatment plans have positively influenced the market growth in Europe. Other factors, such as the widespread use of corticosteroid drugs for the effective treatment of dry eye syndrome and rising consumer healthcare expenditure capacities, are also contributing to the market's positive outlook.
Request a Free Sample Report: https://www.imarcgroup.com/europe-dry-eye-syndrome-market/requestsample
Europe Dry Eye Syndrome Market 2022-2027 Analysis and Segmentation:
The report has segmented the market on the basis on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
- Evaporative Dry Eye Syndrome
- Aqueous Dry Eye Syndrome
Breakup by Drug Type:
- Anti-inflammatory Drugs
- Lubricant Eye Drops
- Autologous Serum Eye Drops
Breakup by Product:
- Liquid Drops
- Gel
- Liquid Wipes
- Eye Ointment
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Breakup by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4916&flag=C
Other Trending Report by IMARC Group
Conditional Access System (CAS) Market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
